Ondansetron Orally Disintegrating Tablets
SPE2D2-25-R-0018 · DEPT OF DEFENSE
A PHARMACEUTICAL PREPARATION MANUFACTURING solicitation, with responses due 2026-04-22. AwardCast estimates what this specific solicitation will close for, before you bid.
SPE2D2-25-R-0018
solicitation
325412
NAICS
6505
PSC
Not set aside
set-aside
2026-04-22
responses due
What's being bought
Amendment 0004 issued since this procurement is using the procedures of 41 U.S.C. 1901, as implemented by Class Deviation 2026-O0028 Revolutionary Federal Acquisition Regulation (FAR) Overhaul Part 12, Defense FAR Supplement (DFARS) Part 212 and Revolutionary FAR Overhaul Part 12.201-1. See updated
Comparable recent awards in PHARMACEUTICAL PREPARATION MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| SR-SERVICES GMBH | $25K | 2 | 2024-09-30 |
| AMERICAN REGENT INC | $926 | n/a | 2024-09-30 |
| PFIZER INC | $2.2M | 4 | 2024-09-30 |
| ADVANCED ACCELERATOR APPLICATIONS USA INC | $1.9M | n/a | 2024-09-30 |
| FRESENIUS KABI USA, LLC | $5.4M | 4 | 2024-09-30 |
Explore the market
Comparable awards ran from $926 to $5.4M. Get AwardCast's forecast for THIS solicitation's closing price.
AwardCast forecasts what U.S. federal contracts close for, before you bid. Built on USASpending and SAM.gov. Not affiliated with the U.S. government. Technology by Chosing DEPT.